An unusual case of opsoclonus-myoclonus-ataxia syndrome associated neuroblastoma: High-risk disease requiring immunotherapy

Pediatr Blood Cancer. 2020 Nov;67(11):e28393. doi: 10.1002/pbc.28393. Epub 2020 Aug 15.

Authors

Jessica Stiefel¹, Ellen Basu¹, Rina Meyer², Gurcharanjeet Kaur³, Yasmin Khakoo^{1

4

5}

Affiliations

¹ Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
² Stony Brook Cancer Center, Stony Brook, New York.
³ Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware.
⁴ Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
⁵ Department of Pediatrics, Weill Medical College of Cornell University, New York, New York.

PMID: 32798258
DOI: 10.1002/pbc.28393

No abstract available

Publication types

Case Reports
Letter
Research Support, N.I.H., Extramural

MeSH terms

Ataxia / complications
Ataxia / pathology
Ataxia / therapy*
Humans
Immunotherapy / methods*
Infant
Male
Neuroblastoma / complications
Neuroblastoma / pathology
Neuroblastoma / therapy*
Opsoclonus-Myoclonus Syndrome / complications
Opsoclonus-Myoclonus Syndrome / pathology
Opsoclonus-Myoclonus Syndrome / therapy*
Prognosis

Grants and funding

P30 CA008748/CA/NCI NIH HHS/United States